Skip to main content

Table 1 Characteristics of the study population with paired cervical and oral samples, stratified by human immunodeficiency virus (HIV) status

From: Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in Brazil

 

HIV+ N = 115

HIV- N = 139

OR (CI)

P

N (%)

N (%)

Age cohort (years)

Mean

42.17

41.4

0.8

0.4

 18–30

16 (13.9)

31 (22.3)

1

 

 31–40

36 (31.3)

37 (26.6)

1.93 (0.88–4.08)

0.09

  > 40

63 (54.8)

71 (51.1)

1.72 (0.84–3.36)

0.12

School education (years)

  < 8

45 (39.1)

26 (18.7)

2.79 (1.55–5.00)

0.0003

  ≥ 8

70 (60.9)

113 (81.3)

1

–

Marital status

 Married

53 (46.1)

68 (48.9)

1

 

 Unmarried

45 (39.1)

66 (47.5)

1.14 (0.67–1.95)

0.69

 Widowed

17 (14.8)

5 (3.6)

0.22 (0.08–0.61)

0.004

Skin color

 White

48 (41.7)

81 (58.2)

1

 

 Not white

67 (58.2)

58 (41.7)

1.94 (1.17–3.24)

0.009

Menarche (years)

  < 13

56 (48.7)

78 (56.1)

1

 

  ≥ 13

59 (51.3)

61 (43.9)

1.34 (0.80–2.18)

0.25

Age of sexual debut (years)

  < 18

79 (68.7)

78 (56.1)

1.71 (1.02–2.89)

0.04

  ≥ 18

36 (31.3)

61 (43.9)

1

 

Sexual partners (number)

 1

6 (5.2)

24 (17.3)

1

 

 2–7

77 (66.9)

82 (59)

3.75 (1.43–9.28)

0.004

  > 7

32 (27.9)

33 (23.7)

3.87 (1.36–10.68)

0.007

Parity (number)

 0

3 (2.6)

26 (18.7)

1

 

 1–2

59 (51.3)

77 (55.4)

6.64 (2.14–21.50)

0.0006

  ≥ 3

53 (46.1)

36 (25.9)

12.76 (3.84–41.68)

< 0.0001

History of cytology in the past three years

 Yes

42 (36.5)

73 (52.5)

1

 

 No

73(63.5)

66 (47.5)

1.92 (1.15–3.20)

0.01

Hormonal contraceptive use

 Yes

20 (17.4)

37 (26.6)

1

 

 No

95 (82.6)

102 (73.4)

1.72 (0.93–3.19)

0.08

Gynecologic infections

 Yes

30 (26.1)

29 (20.8)

1

 

 No

85 (73.9)

110 (79.1)

1.33 (0.74–2.40)

0.37

Cigarette smoking

 Yes

30 (26.1)

32 (23)

1

 

 No

56 (48.7)

85 (61.1)

1.2

0.3

 Ex-smoker

29 (25.2)

22 (15.8)

0.6

0.1

HIV diagnosis (years)

  < 5

73 (63.5)

–

–

–

 -10

42 (36.5)

–

–

–

  > 10

0 (0)

–

–

–

HAART compliance

 Yes

93 (80.9)

–

–

–

 No

22 (19.1)

–

–

–

Current CD4 (cells/mm3)

  < 200

3 (2.6)

–

–

–

 200–350

17 (14.8)

–

–

–

  > 350

95 (82.6)

–

–

–

Most recent viral load

 Undetectable

99 (86.1)

–

–

–

 Detectable

16 (13.9)

–

–

–

  1. HAART, highly active antiretroviral therapy; OR = Odds ratio; CI = confidence interval